Branded Legacy, Inc. Secures Key Client with $70,000,000 Annual Revenue; Expects to Surpass $10,000,000 in 2025

Rhea-AI Summary

Branded Legacy, Inc. (OTC.PK: BLEG) has secured a significant client, Monster Group, Inc., with $70,000,000 in annual revenue. This partnership is expected to boost Branded Legacy's revenue to over $10,000,000 annually by 2025. The company's subsidiary, Sycamore BioPharma, will provide high-quality mitragynine salt for the client's product lines sold across the Middle East, Europe, and North America.

The current supply line is generating approximately $60,000 weekly for Branded Legacy, with a 500% growth target set for the next six months. The company plans to take over lab operations for this client within 6 to 10 months. Additionally, Branded Legacy's subsidiary Royal Biotek is in negotiations with a large distributor for Delta 8 and Delta 9 distillate, potentially leading to similar revenue figures.

CEO Dave Oswald stated that this development positions Branded Legacy to be self-funded moving forward, reducing the need for additional funding. The company is also in talks with several potential acquisition candidates to complement its existing operations and strategic growth plans.

Positive

• Secured a key client (Monster Group, Inc.) with $70,000,000 annual revenue
• Expected to generate over $10,000,000 annually in revenue by 2025
• Current supply line generating approximately $60,000 weekly
• 500% growth target set for the next six months
• Potential expansion of product line with additional commodities
• Negotiations with large distributor for Delta 8 and Delta 9 distillate
• Positioned to become self-funded, reducing need for additional funding
• In talks with potential acquisition candidates

Negative

• None.

500% Growth Target Has Been Set For The Next Six Months of Operations

MELBOURNE, Fla., Oct. 1, 2024 /PRNewswire/ -- Branded Legacy, Inc.,(OTC.PK: BLEG) a leading supplier of botanical extracts and alkaloid-based compounds, is excited to announce that it has sent its first invoice to Monster Group, Inc. a multinational product manufacturer and distributor generating over $70,000,000 in annual revenue. This partnership marks a significant milestone and is expected to act as a catalyst that will propel Branded Legacy into generating over $10,000,000 annually in revenue by 2025.

The partnership commences with Branded Legacy's subsidiary Sycamore BioPharma providing high-quality mitragynine salt, which will be integrated into the client's product lines which are sold across the Middle East, Europe, and North America. Branded Legacy will take over lab operations for this client over the next 6 to 10 months. The current supply line is generating approximately $60,000 weekly for the company, and a 500% growth target has been set for the next six months of operations. Discussions for expanding the product line with several additional commodities are already underway.

In addition, Branded Legacy's subsidiary Royal Biotek has been engaged in negotiations with a large distributor to provide Delta 8 and Delta 9 distillate, which could lead to similar revenue figures in the near future.

"This announcement is the culmination of months of dedicated work and negotiations," said Dave Oswald, CEO of Branded Legacy, Inc. "While we have always been cautious about sharing sensitive deal information until it's finalized, I'm pleased to confirm that this development positions us to be a self-funded company moving forward, reducing the need to seek additional funding."

Branded Legacy has also been in talks with several potential acquisition candidates, with discussions accelerating rapidly. These candidates include companies that complement Branded Legacys' existing operations and strategic growth plans. 

About Branded Legacy, Inc.
Branded Legacy, Inc. is a leading supplier of botanical extracts, specializing in high-quality, sustainable ingredients for use in supplements and wellness products..

Original Copy of this Press Release: https://brandedlegacy.com/branded-legacy-inc-secures-key-client/

For more information, please contact:
Joe Holladay
Branded Legacy
Phone: 321-345-3565
Email: info@brandedlegacy.com

Website: https://brandedlegacy.com/

Branded Legacy, Inc. (OTC: BLEG) is a diversified holdings company focused on the biotech sector. With a commitment to excellence and innovation, Branded Legacy specializes in the development and marketing of cutting-edge products and services, including ventures in biotechnology, digital solutions, and wellness products.

Safe Harbor Statement on Forward-Looking Language:

This release includes forward-looking statements, subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The company disclaims any intention or obligation to update or revise forward-looking statements. Forward-looking statements may be identified by words such as "may," "will," "expect," "believe," "anticipate," "estimate," and similar expressions.

View original content:https://www.prnewswire.com/news-releases/branded-legacy-inc-secures-key-client-with-70-000-000-annual-revenue-expects-to-surpass-10-000-000-in-2025--302263873.html

SOURCE Branded Legacy, Inc.

FAQ

What is Branded Legacy's (BLEG) revenue target for 2025?

Branded Legacy (BLEG) expects to surpass $10,000,000 in annual revenue by 2025, driven by its new partnership with Monster Group, Inc.

How much weekly revenue is Branded Legacy (BLEG) currently generating from its new supply line?

Branded Legacy (BLEG) is currently generating approximately $60,000 weekly from its new supply line with Monster Group, Inc.

What growth target has Branded Legacy (BLEG) set for the next six months?

Branded Legacy (BLEG) has set a 500% growth target for the next six months of operations following its partnership with Monster Group, Inc.

What product is Branded Legacy (BLEG) providing to Monster Group, Inc.?

Branded Legacy's (BLEG) subsidiary Sycamore BioPharma is providing high-quality mitragynine salt to Monster Group, Inc. for integration into their product lines.